Buruli ulcer (Mycobacterium ulcerans infection). (Q34594767)

3 August 2017

1 reference

title

Buruli ulcer (Mycobacterium ulcerans infection). (English)

1 reference

3 August 2017

Mycobacterium ulcerans

0 references

2

Françoise Portaels

1 reference

3 August 2017

Douglas S Walsh

1

1 reference

PubMed ID

18657836

3 August 2017

Wayne M Meyers

series ordinal

3

1 reference

3 August 2017

26 July 2008

1 reference

Transactions of the Royal Society of Tropical Medicine and Hygiene

3 August 2017

1 reference

3 August 2017

102

1 reference

3 August 2017

969-978

1 reference

3 August 2017

10

1 reference

PCR amplification with primers based on IS2404 and GC-rich repeated sequence reveals polymorphism in Mycobacterium ulcerans.

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

Mycobacterium ulcerans toxic macrolide, mycolactone modulates the host immune response and cellular location of M. ulcerans in vitro and in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

Psychosocial aspects of health seeking behaviours of patients with Buruli ulcer in southern Benin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

Promising clinical efficacy of streptomycin-rifampin combination for treatment of buruli ulcer (Mycobacterium ulcerans disease)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

Ulcerative cutaneous mycobacteriosis due to Mycobacterium ulcerans: report of two Mexican cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

Modulation of the host immune response by a transient intracellular stage of Mycobacterium ulcerans: the contribution of endogenous mycolactone toxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

The phenolic mycoside of Mycobacterium ulcerans: structure and taxonomic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

First case of Mycobacterium ulcerans disease (Buruli ulcer) following a human bite

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

Mycobacterium ulcerans disease (Buruli ulcer) in rural hospital, Southern Benin, 1997-2001

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

Mycobacterium ulcerans disease: role of age and gender in incidence and morbidity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

Buruli ulcer recurrence, Benin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

MYCOBACTERIAL SKIN ULCERS IN UGANDA: HISTOPATHOLOGICAL AND EXPERIMENTAL ASPECTS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

Pathways of Mycobacterium ulcerans infection: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

Primary culture of Mycobacterium ulcerans from human tissue specimens after storage in semisolid transport medium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

Mycolactone is responsible for the painlessness of Mycobacterium ulcerans infection (buruli ulcer) in a murine study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

Buruli ulcer in a visitor to London

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

First reported case of Mycobacterium ulcerans infection in a patient from China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

Histopathologic features of Mycobacterium ulcerans infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

Mycobacterium ulcerans disease, Peru.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

Disseminated Mycobacterium ulcerans disease in an HIV-positive patient: a case study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

Mycobacterium ulcerans in mosquitoes captured during outbreak of Buruli ulcer, southeastern Australia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

Association of HIV infection and Mycobacterium ulcerans disease in Benin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

The local immune response in ulcerative lesions of Buruli disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

Toxin of Mycobacterium ulcerans. Production and effects in guinea pig skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

A new mycobacterial infection in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

Aquatic insects as a vector for Mycobacterium ulcerans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

Colonization of the salivary glands of Naucoris cimicoides by Mycobacterium ulcerans requires host plasmatocytes and a macrolide toxin, mycolactone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

Impact of Mycobacterium ulcerans biofilm on transmissibility to ecological niches and Buruli ulcer pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

Emergence of Buruli ulcer disease in the Daloa region of Cote d'Ivoire.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

Human Mycobacterium ulcerans infections developing at sites of trauma to skin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

Mycobacterium ulcerans infection (Buruli ulcer): first reported patients in Togo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

Heterogeneity of mycolactones produced by clinical isolates of Mycobacterium ulcerans: implications for virulence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

Environmental and health-related risk factors for Mycobacterium ulcerans disease (Buruli ulcer) in Benin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

"Mycobacterium ulcerans subsp. shinshuense" isolated from a skin ulcer lesion: identification based on 16S rRNA gene sequencing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

Mycobacterium ulcerans disease (Buruli ulcer) in a rural hospital in Bas-Congo, Democratic Republic of Congo, 2002-2004.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

Immunosuppressive properties of the soluble toxin from Mycobacterium ulcerans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

Insects in the transmission of Mycobacterium ulcerans infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

Mycobacterium bovis BCG vaccination as prophylaxis against Mycobacterium ulcerans osteomyelitis in Buruli ulcer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

First cultivation and characterization of mycobacterium ulcerans from the environment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

Risk factors for buruli ulcer: a case control study in Cameroon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

Buruli ulcer: a systemic disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

Risk factors for Mycobacterium ulcerans infection, southeastern Australia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

Development and application of real-time PCR assay for quantification of Mycobacterium ulcerans DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

Development of highly organized lymphoid structures in Buruli ulcer lesions after treatment with rifampicin and streptomycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

Dry-reagent-based PCR as a novel tool for laboratory confirmation of clinically diagnosed Mycobacterium ulcerans-associated disease in areas in the tropics where M. ulcerans is endemic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

Susceptibility to Buruli ulcer is associated with the SLC11A1 (NRAMP1) D543N polymorphism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

Identification of Mycobacterium ulcerans in the environment from regions in Southeast Australia in which it is endemic with sequence capture-PCR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

Giant plasmid-encoded polyketide synthases produce the macrolide toxin of Mycobacterium ulcerans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

Heterogeneity among Mycobacterium ulcerans isolates from Africa.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

Aggressive multifocal Buruli ulcer with associated osteomyelitis in an HIV-positive patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

Evidence for an intramacrophage growth phase of Mycobacterium ulcerans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

A large localized outbreak of Mycobacterium ulcerans infection on a temperate southern Australian island

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

The Philippine cynomolgus monkey (Macaca fasicularis) provides a new nonhuman primate model of tuberculosis that resembles human disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

Buruli ulcer: emerging from obscurity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

Identification and characterization of IS2404 and IS2606: two distinct repeated sequences for detection of Mycobacterium ulcerans by PCR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

inferred from DOI database lookup

7 January 2021

based on heuristic

Transmission of Mycobacterium ulcerans to the nine-banded armadillo

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.06.006

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TRSTMH.2008.06.006

1 reference

3 August 2017

1 reference

PubMed ID

18657836